Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology
On February 20, Friends of Cancer Research, Duke-Margolis Center for Health Policy, Reagan-Udall Foundation for the FDA, and Aetion co-hosted "Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology." This collaborative workshop convened a wide array of stakeholders, including regulatory experts, academia, clinicians, patients, advocates, data vendors, and biopharma representatives. The event discussed and identified pressing gaps in real-world data (RWD) collection and accessibility and dove into the importance of ensuring that real-world evidence (RWE) generation is relevant to patient care.